We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Woodcock: Submit PRO Measures Early, Use to Check Quality of Life
Woodcock: Submit PRO Measures Early, Use to Check Quality of Life
December 7, 2011
Drug trial sponsors developing patient-reported outcome (PRO) measures should seek FDA qualification for those tools prior to clinical trials and should use them to gauge quality of life, CDER Director Janet Woodcock advises.